New Orleans-based Ochsner Health requires genome testing for two cancer drugs, which can determine a patient’s metabolism to provide better patient outcomes.
Read the full post on Becker's Hospital Review - Healthcare News
How Oschner is leading the curve with universal genome testing for chemo
